IBDEI0YO ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17227,1,1,0)
 ;;=1^206.81
 ;;^UTILITY(U,$J,358.3,17227,1,8,0)
 ;;=8^Oth Monocytic Leuk w/ Remiss
 ;;^UTILITY(U,$J,358.3,17227,2)
 ;;=^267551
 ;;^UTILITY(U,$J,358.3,17228,0)
 ;;=206.82^^111^1077^39
 ;;^UTILITY(U,$J,358.3,17228,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17228,1,1,0)
 ;;=1^206.82
 ;;^UTILITY(U,$J,358.3,17228,1,8,0)
 ;;=8^Oth Monocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,17228,2)
 ;;=^336479
 ;;^UTILITY(U,$J,358.3,17229,0)
 ;;=206.90^^111^1077^62
 ;;^UTILITY(U,$J,358.3,17229,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17229,1,1,0)
 ;;=1^206.90
 ;;^UTILITY(U,$J,358.3,17229,1,8,0)
 ;;=8^Unspec Monocytic Leuk w/o Remiss
 ;;^UTILITY(U,$J,358.3,17229,2)
 ;;=^336865
 ;;^UTILITY(U,$J,358.3,17230,0)
 ;;=206.91^^111^1077^61
 ;;^UTILITY(U,$J,358.3,17230,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17230,1,1,0)
 ;;=1^206.91
 ;;^UTILITY(U,$J,358.3,17230,1,8,0)
 ;;=8^Unspec Monocytic Leuk in Remiss
 ;;^UTILITY(U,$J,358.3,17230,2)
 ;;=^267554
 ;;^UTILITY(U,$J,358.3,17231,0)
 ;;=206.92^^111^1077^60
 ;;^UTILITY(U,$J,358.3,17231,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17231,1,1,0)
 ;;=1^206.92
 ;;^UTILITY(U,$J,358.3,17231,1,8,0)
 ;;=8^Unspec Monocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,17231,2)
 ;;=^336480
 ;;^UTILITY(U,$J,358.3,17232,0)
 ;;=207.00^^111^1077^3
 ;;^UTILITY(U,$J,358.3,17232,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17232,1,1,0)
 ;;=1^207.00
 ;;^UTILITY(U,$J,358.3,17232,1,8,0)
 ;;=8^AC Eryth & Erythroleuk w/o Remiss
 ;;^UTILITY(U,$J,358.3,17232,2)
 ;;=^336866
 ;;^UTILITY(U,$J,358.3,17233,0)
 ;;=207.01^^111^1077^1
 ;;^UTILITY(U,$J,358.3,17233,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17233,1,1,0)
 ;;=1^207.01
 ;;^UTILITY(U,$J,358.3,17233,1,8,0)
 ;;=8^AC Eryth & Erythroleuk in Relapse
 ;;^UTILITY(U,$J,358.3,17233,2)
 ;;=^267556
 ;;^UTILITY(U,$J,358.3,17234,0)
 ;;=207.02^^111^1077^2
 ;;^UTILITY(U,$J,358.3,17234,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17234,1,1,0)
 ;;=1^207.02
 ;;^UTILITY(U,$J,358.3,17234,1,8,0)
 ;;=8^AC Eryth & Erythroleuk in Relapse
 ;;^UTILITY(U,$J,358.3,17234,2)
 ;;=^336481
 ;;^UTILITY(U,$J,358.3,17235,0)
 ;;=207.10^^111^1077^9
 ;;^UTILITY(U,$J,358.3,17235,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17235,1,1,0)
 ;;=1^207.10
 ;;^UTILITY(U,$J,358.3,17235,1,8,0)
 ;;=8^Chr Erythremia w/o Remission
 ;;^UTILITY(U,$J,358.3,17235,2)
 ;;=^336867
 ;;^UTILITY(U,$J,358.3,17236,0)
 ;;=207.11^^111^1077^8
 ;;^UTILITY(U,$J,358.3,17236,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17236,1,1,0)
 ;;=1^207.11
 ;;^UTILITY(U,$J,358.3,17236,1,8,0)
 ;;=8^Chr Erythremia in Remission
 ;;^UTILITY(U,$J,358.3,17236,2)
 ;;=^267558
 ;;^UTILITY(U,$J,358.3,17237,0)
 ;;=207.12^^111^1077^7
 ;;^UTILITY(U,$J,358.3,17237,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17237,1,1,0)
 ;;=1^207.12
 ;;^UTILITY(U,$J,358.3,17237,1,8,0)
 ;;=8^Chr Erythremia in Relapse
 ;;^UTILITY(U,$J,358.3,17237,2)
 ;;=^336482
 ;;^UTILITY(U,$J,358.3,17238,0)
 ;;=207.20^^111^1077^28
 ;;^UTILITY(U,$J,358.3,17238,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17238,1,1,0)
 ;;=1^207.20
 ;;^UTILITY(U,$J,358.3,17238,1,8,0)
 ;;=8^Megakaryocytic Leuk w/o Remission
 ;;^UTILITY(U,$J,358.3,17238,2)
 ;;=^336868
 ;;^UTILITY(U,$J,358.3,17239,0)
 ;;=207.21^^111^1077^27
 ;;^UTILITY(U,$J,358.3,17239,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17239,1,1,0)
 ;;=1^207.21
 ;;^UTILITY(U,$J,358.3,17239,1,8,0)
 ;;=8^Megakaryocytic Leuk in Remission
 ;;^UTILITY(U,$J,358.3,17239,2)
 ;;=^267560
 ;;^UTILITY(U,$J,358.3,17240,0)
 ;;=207.22^^111^1077^26
 ;;^UTILITY(U,$J,358.3,17240,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17240,1,1,0)
 ;;=1^207.22
